Eolas Medical has raised US$12m in series A funding to scale its AI search tools within the NHS.
Its platform is already used at more than 400 clinical sites in the UK, according to the company.
The Northern Irish health-tech start-up said its AI search platform aims to provide “point-of-care knowledge tools supporting clinical safety, adherence and productivity” via a “single, searchable source of truth … up to 10 times faster than traditional methods”.
Eolas founder and chief executive Dr Declan Kelly said: “Eolas has always been about solving a very practical problem: giving healthcare professionals fast, reliable access to the knowledge they need, when they need it.
“This is especially important in acute settings, where staff are under pressure to make decisions quickly and safely – particularly in the winter.”
The platform is already used at more than 400 clinical sites in the UK, according to the company, and aims to help improve the speed and quality of decision-making of medical staff by removing the need to work with fragmented or outdated information sources.
Kelly said: “As AI develops, the next phase is about making that access even more usable, so staff can ask a question and get a clear, evidence-backed answer straight away, in plain language.”
Belfast-based Eolas was built by Kelly and other doctors in response to the professional challenges and frustrations they experienced.
It aims to “capture, organise and mobilise the world’s medical knowledge, ensuring seamless access for healthcare professionals at the point of care”.
Acton Capital led the funding round.
Acton managing partner Fritz Oidtmann said: “Our conversations with clinicians showed remarkable enthusiasm for Eolas. Clinicians love the product.
“The benefit is immediate, the value is clear, and this conviction and their unique positioning in the market strongly shaped our excitement to partner with Eolas Medical.”
